Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational oral
SOUTH SAN FRANCISCO, Calif., Oct. 7, 2021 /PRNewswire/ -- A Duke University-led study published in bioRxiv showed that Vaxart, Inc.'s (NASDAQ: VXRT) investigational oral tablet vaccine reduced the air
Vaxart (VXRT) commences recruiting subjects in its mid-stage study for its oral vaccine tablet for COVID-19. It will begin dosing in the United States later this month.

Why Vaxart Stock Tumbled in September

10:00am, Thursday, 07'th Oct 2021
A COVID-19 antiviral pill may undermine the biotech's value proposition.

Why Investing in VXRT Stock is a Coin Flip

12:03pm, Wednesday, 06'th Oct 2021
Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. The post Why Investing in VXRT Stock is a Coin Flip appeared first on InvestorPlace.
Vaxart (VXRT) has been struggling lately, but the selling pressure may be coming to an end soon.

What's Going On With Vaxart's Stock?

05:47pm, Tuesday, 05'th Oct 2021
Vaxart Inc. (NASDAQ: VXRT) shares traded higher Tuesday after a study titled "A Phase 2 Trial With an Oral Tableted Covid-19 Vaccine" was posted to Clinicaltrials.gov. This may have inspired retail tr
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
SAN DIEGO, Oct. 2, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, investigates potential claims on behalf of Vaxart, Inc. (NASDAQ: VXRT) against certain of its officers for vi
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector. The post Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks
Good news from Merck and Ridgeback caused these stocks to fall.
The recently range-bound price action of VXRT stock doesn't reflect the progress that Vaxart is making against Covid-19. The post Vaxart Traders Should Not Dismiss the Vaccine Maker's Momentum appeare
SOUTH SAN FRANCISCO, Calif., Sept. 22, 2021 /PRNewswire/ -- Vaxart, Inc. (NASDAQ: VXRT), today announced that one of the company's senior scientists, Susan Johnson PhD, will present at both ID Week 2
SOUTH SAN FRANCISCO, Calif., Sept. 21, 2021 /PRNewswire/ -- Vaxart, Inc. (NASDAQ: VXRT), today announced that it has formed a Manufacturing and Quality Advisory Board.
These under-the-radar companies are expected to deliver jaw-dropping revenue growth over the next four years.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE